Would Trump rescheduling cannabis boost reform in Congress? (Newsletter: October 20, 2025)

October 20, 2025

Michigan marijuana tax increase, and the bill it hands to everyone else

Michigan marijuana tax increase. Say it out loud. It sounds like a surcharge on optimism. A fresh bite taken out of a maturing market that finally learned to walk, only to find a new ankle weight strapped on by the state. This is cannabis taxation in the Midwest’s busiest legal hub, where a wholesale levy now shadows every gram and gummy. The Michigan cannabis market has grown up fast. It pumps legal cannabis revenue into city coffers and school funds, feeds payrolls from the grow room to the storefront, and—if we’re honest—keeps a few small towns alive. But the new tax lands like a dish left too long on the pass: overdone, a little bitter, and sent back by operators who’ve been pulling double shifts just to keep margins from burning. If you want to understand cannabis industry impact, start with price. Then follow the receipt to policy.

Michigan’s scramble to fix the tab

In Lansing, lawmakers know the kitchen is too hot. Hearings kicked off to ease the regulatory pinch just days after the levy arrived, a tacit admission that policy timing matters as much as policy substance. The conversation centers on trimming compliance redundancies, cutting wait times, and smoothing licensing so the market can absorb the hit without flinching at the register. That’s not charity. It’s survival tactics in a tax-forward environment where the illicit market still whispers deals in alleyways and Telegram chats. For a sector already wrestling with falling wholesale prices, the catch-22 is cruel: sell more to make less, and pay more for the privilege. If you want a blow-by-blow on the proposals moving through committee, see Michigan Senators Weigh Marijuana Regulatory Reform Bills To Aid Industry Reeling From New Tax Increase. The broader lesson lands like a shot of Fernet: taxes that outpace reform don’t just skim the top—they hollow out the middle, where mom-and-pop operators live. A smarter recipe balances revenue with relief.

Pennsylvania eyes a different kitchen layout

Now look east. Pennsylvania is flirting with a structural reset, not a bandage. Senators are set to vote on a bipartisan bill to create a Cannabis Control Board, a single counter where rules, oversight, and—eventually—adult-use could coexist without the bureaucratic relay race that kills momentum. That’s marijuana policy reform built for longevity. Standardize the playbook. Cut the echo of conflicting directives. Put one coach on the sideline and let the team run. If you care about stability, this is the play to watch: Pennsylvania Senators Will Vote On Bipartisan Cannabis Bill To Create New Regulatory Body Next Week. The move doubles as a warning to other states flirting with recriminalization stunts or ballot mischief. In Massachusetts, for instance, talk of rolling back adult-use sales came with a reminder that those cannabis taxes are paying for services people actually use—treatment beds, public health programs, the unglamorous plumbing of government. Pull that thread and the sweater unravels fast. Markets crave clarity. Voters do too, especially when the receipts already fund the neighborhood.

Two snapshots from the edges: Nebraska and Maryland

On the Plains, another story simmers. Nebraska’s medical program sits on a knife’s edge, and a governor-appointed panel floated restrictive rules that advocates say would strangle access before the first patient card is printed. The testimony was unanimous and sharp. People in pain don’t care about political choreography—they care about getting what works without a scavenger hunt. If you want the unfiltered pushback, take the time: Nebraska Medical Marijuana Supporters Slam Restrictive Rules Proposed By Governor-Appointed Panel. Down on the Atlantic coast, a different theater played out. Maryland police put out a call for volunteers to consume cannabis for DUI recognition training. Hundreds raised their hands for science, free lunch, and a safe, supervised setting. The story reads like a punchline, but the subtext is sober: enforcement evolves, and responsible impairment training matters in any legal market. Catch the scene here: Maryland Police Get ‘Overwhelming’ Number Of Volunteers To Smoke Marijuana And Eat Free Lunch At DUI Training For Officers. Together, these snapshots tell you why national headlines miss the flavor. Cannabis isn’t one market. It’s a patchwork stew of rules, taxes, and cultural detours.

The stakes: pain, policy, and the bill we all pay

Here’s the part that never fits neatly on a placard: legalization has public health gravity. A federally funded study published by the American Medical Association found that legal access—medical or adult-use—was linked to reduced opioid use among cancer patients. Fewer pills. Fewer refills. More control over pain on a schedule that belongs to the patient, not a pharmacy queue. That’s not a miracle cure. It’s policy that nudges the system toward harm reduction. When you weigh a Michigan marijuana tax increase—or any cannabis taxation scheme—against outcomes like that, the calculus changes. You don’t just tally legal cannabis revenue or the margin on a pre-roll. You count avoided hospital visits, safer sleep, and families spared from the quiet ruin of dependency. Keep your eye on the pillars that actually hold this house up: balanced tax policy, clean and efficient regulation, real access for patients, and enforcement that trains for reality, not fantasy. If you want a cheat sheet, try this:

  • Tax design that funds services without crushing small operators.
  • One regulator with clear lanes. Fewer cooks, better broth.
  • Patient-first rules that don’t gatekeep relief.
  • Training and data, not moral panic, for public safety.

In a country still learning how to serve cannabis without burning the edges, the winning kitchens are humble and precise. They season for the long haul, not the headline. If you’re ready to explore craft that respects the plant and the palate, pull up a chair and visit our shop: https://thcaorder.com/shop/.

Leave a Reply

Subscribe

Get Weekly Discounts & 15% Off Your 1st Order.

    FDA disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease. All information presented here is not meant as a substitute for or alternative to information from health care practitioners. Please consult your healthcare professional about potential interactions or other possible complications before using any product. The Federal Food, Drug, and Cosmetic Act requires this notice.

    Please Note: Due to current state laws, we are unable to ship THCa products to the following states: Arkansas, Idaho, Minnesota, Oregon, Rhode Island.
    Select the fields to be shown. Others will be hidden. Drag and drop to rearrange the order.
    • Image
    • SKU
    • Rating
    • Price
    • Stock
    • Availability
    • Add to cart
    • Description
    • Content
    • Weight
    • Dimensions
    • Additional information
    Click outside to hide the comparison bar
    Compare
    Home
    Shopping
    Account